Skip to search formSkip to main contentSkip to account menu

KRAS NM_004985.3:c.34_35delGGinsTT

Known as: v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog c.34_35GG>TT, NM_004985.3:c.34_35delGGinsTT, KRAS c.34_35GG>TT 
A complex substitution where the nucleotide sequence at positions 34 through 35 of the coding sequence of the KRAS gene has changed from guanine… 
National Institutes of Health

Related topics

Related topics

1 relation
KRAS gene

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Safety and immunogenicity of a CRM or TT conjugated meningococcal vaccine in healthy toddlers.
2013
2013
Infant Meningococcal Vaccination: Advisory Committee on Immunization Practices (ACIP) Recommendations and Rationale
At its October 2012 meeting, the Advisory Committee on Immunization Practices (ACIP) voted to recommend vaccination against… 
2013
2013
Antibody Persistence for up to 5 Years After a Fourth Dose of Haemophilus influenzae Type b and Neisseria Meningitidis Serogroups C and Y–Tetanus Toxoid Conjugate Vaccine (HibMenCY-TT) Given at 12–15…
Background: A 4-dose series of recently licensed Haemophilus influenzae type b–meningococcal serogroups C and Y-tetanus toxoid… 
2012
2012
Persistence of Antibody Response Following a Booster Dose of Hib-MenC-TT Glycoconjugate Vaccine to Five Years: A Follow-up Study
Background: Antibodies against Haemophilus influenzae type b (Hib) and serogroup C Neisseria meningitidis (MenC) persist better… 
2012
2012
Five-year Antibody Persistence and Safety Following a Booster Dose of Combined Haemophilus influenzae Type b–Neisseria meningitidis Serogroup C–Tetanus Toxoid Conjugate Vaccine
Background: Booster vaccination with the combined Haemophilus influenza type b-Neisseria meningitides serogroup C-tetanus toxoid… 
2011
2011
Persistence of Immunity Following a Booster Dose of Haemophilus Influenzae Type B-Meningococcal Serogroup C Glycoconjugate Vaccine: Follow-up of a Randomized Controlled Trial
Background: Antibodies against Haemophilus influenzae type b (Hib) and serogroup C Neisseria meningitidis (MenC) wane after early… 
Review
2011
Review
2011
Haemophilus influenzae type b–Neisseria meningitidis serogroups C and Y tetanus toxoid conjugate vaccine for infants and toddlers
The highest rates of invasive meningococcal disease occur in children under 2 years of age, yet as of early 2011 no vaccine was… 
2008
2008
Fever-range whole-body thermal therapy combined with cisplatin, gemcitabine, and daily interferon-α: A description of a phase I-II protocol
Purpose: The purpose of the Phase I component of this study was to find the maximally tolerated dose (MTD) of cisplatin… 
1998
1998
Development of an animal model to assess the immunogenicity of single-dose tetanus and diphtheria vaccines based on controlled release from biodegradable polymer microspheres.
We have determined threshold doses of aluminium phosphate (AlPO4) adsorbed tetanus toxoid (TT) and diphtheria toxoid (DT) in mice… 
1976
1976
Clinical profile and toxicology studies on four women immunized with Pr-β-HCG-TT
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)